newsfilter
← Latest News
GlobeNewswire·

Apollomics Regains Full Compliance with Nasdaq Listing Requirements

FOSTER CITY, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company developing multiple oncology drug